User profiles for Patrick May
Patrick MayGenome Analysis, Bioinformatics Core, Luxembourg Centre for Systems Biomedicine Verified email at uni.lu Cited by 11540 |
Attentive novelty detection in humans is governed by pre-attentive sensory memory
H Tiitinen, P May, K Reinikainen, R Näätänen - Nature, 1994 - nature.com
BEING able to detect unusual, possibly dangerous events in the environment is a fundamental
ability that helps ensure the survival of biological organisms 1–3 . Novelty detection …
ability that helps ensure the survival of biological organisms 1–3 . Novelty detection …
Human posterior auditory cortex gates novel sounds to consciousness
Life or death in hostile environments depends crucially on one's ability to detect and gate
novel sounds to awareness, such as that of a twig cracking under the paw of a stalking …
novel sounds to awareness, such as that of a twig cracking under the paw of a stalking …
[HTML][HTML] Synaptic activity regulates interstitial fluid amyloid-β levels in vivo
…, KA Yamada, MB Finn, RS Sloviter, KR Bales, PC May… - Neuron, 2005 - cell.com
Aggregation of the amyloid-β (Aβ) peptide in the extracellular space of the brain is central to
Alzheimer's disease pathogenesis. Aβ aggregation is concentration dependent and brain …
Alzheimer's disease pathogenesis. Aβ aggregation is concentration dependent and brain …
In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-β metabolism and half-life
JR Cirrito, PC May, MA O'Dell, JW Taylor… - Journal of …, 2003 - Soc Neuroscience
Soluble amyloid-β (Aβ) peptide converts to structures with high β-sheet content in Alzheimer's
disease (AD). Soluble Aβ is released by neurons into the brain interstitial fluid (ISF), in …
disease (AD). Soluble Aβ is released by neurons into the brain interstitial fluid (ISF), in …
[PDF][PDF] ApoE and clusterin cooperatively suppress Aβ levels and deposition: evidence that ApoE regulates extracellular Aβ metabolism in vivo
RB DeMattos, JR Cirrito, M Parsadanian, PC May… - Neuron, 2004 - cell.com
Apolipoprotein E (apoE) and clusterin can influence structure, toxicity, and accumulation of
the amyloid-β (Aβ) peptide in brain. Both molecules may also be involved in Aβ metabolism …
the amyloid-β (Aβ) peptide in brain. Both molecules may also be involved in Aβ metabolism …
Mismatch negativity (MMN), the deviance‐elicited auditory deflection, explained
PJC May, H Tiitinen - Psychophysiology, 2010 - Wiley Online Library
The current review constitutes the first comprehensive look at the possibility that the mismatch
negativity (MMN, the deflection of the auditory ERP/ERF elicited by stimulus change) might …
negativity (MMN, the deflection of the auditory ERP/ERF elicited by stimulus change) might …
Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
LK Simmons, PC May, KJ Tomaselli, RE Rydel… - Molecular …, 1994 - ASPET
Amyloid beta peptide (A beta), the major protein constituent of senile plaques in patients with
Alzheimer's disease, is believed to facilitate the progressive neurodegeneration that occurs …
Alzheimer's disease, is believed to facilitate the progressive neurodegeneration that occurs …
M ercator: a fast and simple web server for genome scale functional annotation of plant sequence data
Next‐generation technologies generate an overwhelming amount of gene sequence data.
Efficient annotation tools are required to make these data amenable to functional genomics …
Efficient annotation tools are required to make these data amenable to functional genomics …
Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor
PC May, RA Dean, SL Lowe, F Martenyi… - Journal of …, 2011 - Soc Neuroscience
According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ)
is critical for Alzheimer's disease (AD) pathogenesis. Aβ generation is initiated when β-…
is critical for Alzheimer's disease (AD) pathogenesis. Aβ generation is initiated when β-…
Nonsteroidal Anti-Inflammatory Drugs Can Lower Amyloidogenic Aß42 by Inhibiting Rho
…, PA Gonzalez-DeWhitt, V Gelfanova, JE Hale, PC May… - Science, 2003 - science.org
A subset of nonsteroidal anti-inflammatory drugs (NSAIDs) has been shown to preferentially
reduce the secretion of the highly amyloidogenic, 42-residue amyloid-β peptide Aβ 42 . We …
reduce the secretion of the highly amyloidogenic, 42-residue amyloid-β peptide Aβ 42 . We …